Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diet and gender influence survival of transgenic Berkley sickle cell mice.

Literature DB >> 30765475

Diet and gender influence survival of transgenic Berkley sickle cell mice.

Om B Jahagirdar¹, Aditya M Mittal¹, Waogwende L Song-Naba¹, Ritu Jha¹, Stacy B Kiven¹, Susan T Thompson¹, John E Connett², Kalpna Gupta³.

Abstract

Entities: Species

Mesh：

Year: 2019 PMID： 30765475 PMCID： PMC6669136 DOI： 10.3324/haematol.2018.208322

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

25 in total

1. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2.

Authors: G J Dover; K D Smith; Y C Chang; S Purvis; A Mays; D A Meyers; C Sheils; G Serjeant
Journal: Blood Date: 1992-08-01 Impact factor: 22.113

2. FOLIC ACID DEFICIENCY IN SICKLE-CELL ANEMIA.

Authors: J LINDENBAUM; F A KLIPSTEIN
Journal: N Engl J Med Date: 1963-10-24 Impact factor: 91.245

3. Total and resting energy expenditure in children with sickle cell disease.

Authors: E M Barden; B S Zemel; D A Kawchak; M I Goran; K Ohene-Frempong; V A Stallings
Journal: J Pediatr Date: 2000-01 Impact factor: 4.406

4. Effect of zinc supplementation on growth and body composition in children with sickle cell disease.

Authors: Babette S Zemel; Deborah A Kawchak; Ellen B Fung; Kwaku Ohene-Frempong; Virginia A Stallings
Journal: Am J Clin Nutr Date: 2002-02 Impact factor: 7.045

Review 5. Micronutrients and sickle cell disease, effects on growth, infection and vaso-occlusive crisis: a systematic review.

Authors: Louise H Dekker; Karin Fijnvandraat; Bernard J Brabin; Michael Boele van Hensbroek
Journal: Pediatr Blood Cancer Date: 2012-04-10 Impact factor: 3.167

6. Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Authors: Mark T Gladwin; Alan N Schechter; Frederick P Ognibene; Wynona A Coles; Christopher D Reiter; William H Schenke; Gyorgy Csako; Myron A Waclawiw; Julio A Panza; Richard O Cannon
Journal: Circulation Date: 2003-01-21 Impact factor: 29.690

7. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.

Authors: Dhananjay K Kaul; Xiaoqin Zhang; Trisha Dasgupta; Mary E Fabry
Journal: Am J Physiol Heart Circ Physiol Date: 2008-05-02 Impact factor: 4.733

8. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Authors: Claudia R Morris; Frans A Kuypers; Lisa Lavrisha; Michael Ansari; Nancy Sweeters; Melinee Stewart; Ginny Gildengorin; Lynne Neumayr; Elliott P Vichinsky
Journal: Haematologica Date: 2013-05-03 Impact factor: 9.941

9. Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial.

Authors: Ahmed A Daak; Kebreab Ghebremeskel; Zahir Hassan; Bakhita Attallah; Haj H Azan; Mustafa I Elbashir; Michael Crawford
Journal: Am J Clin Nutr Date: 2012-11-28 Impact factor: 7.045

10. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

Authors: Julie Makani; Sharon E Cox; Deogratius Soka; Albert N Komba; Julie Oruo; Hadija Mwamtemi; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Brett Lowe; David Muturi; David J Roberts; Thomas N Williams; Kisali Pallangyo; Jesse Kitundu; Gregory Fegan; Fenella J Kirkham; Kevin Marsh; Charles R Newton
Journal: PLoS One Date: 2011-02-16 Impact factor: 3.240

4 in total